✦ LIBER ✦

Temsirolimus in patients with advanced renal cell carcinoma: an overview

✍ Scribed by Shailender Bhatia; John A. Thompson

Book ID: 107648559
Publisher: Springer Healthcare Communications
Year: 2009
Tongue: English
Weight: 240 KB
Volume: 26
Category: Article
ISSN: 0741-238X
DOI: 10.1007/s12325-008-0138-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Quality of life in patients with advance

Quality of life in patients with advanced renal cell carcinoma treated with temsirolimus or interferon-α

✍ Yang, S; de Souza, P; Alemao, E; Purvis, J 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 246 KB

Feasibility of sequential use of sunitin

Feasibility of sequential use of sunitinib and temsirolimus in advanced renal cell carcinoma

✍ Holger Gerullis; Lothar Bergmann; Luise Maute; Thorsten Holger Ecke; Christoph E 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 180 KB

Evaluation of deoxycoformycin in patient

Evaluation of deoxycoformycin in patients with advanced renal cell carcinoma

✍ Robert S. Witte; Christine Walsh; Hugh Fisher; Martin M. Okem; Douglas J. Reding 📂 Article 📅 1992 🏛 Springer US 🌐 English ⚖ 145 KB

Effect of temsirolimus versus interferon

Effect of temsirolimus versus interferon-α on outcome of patients with advanced renal cell carcinoma of different tumor histologies

✍ Janice P. Dutcher; Paul de Souza; David McDermott; Robert A. Figlin; Anna Berken 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 253 KB

Analysis of PTEN and HIF-1α and correlat

Analysis of PTEN and HIF-1α and correlation with efficacy in patients with advanced renal cell carcinoma treated with temsirolimus versus interferon-α

✍ Robert A. Figlin; Paul de Souza; David McDermott; Janice P. Dutcher; Anna Berken 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 324 KB

Pharmacodynamic evaluation of temsirolim

Pharmacodynamic evaluation of temsirolimus in patients with newly diagnosed advanced-stage head and neck squamous cell carcinoma

✍ Oleksandr Ekshyyan; Glenn M. Mills; Timothy Lian; Nazanin Amirghahari; Xiaohua R 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 244 KB 👁 1 views

## Abstract ## Background: Activation of the mammalian target of rapamycin (mTOR) pathway in surgical margins of head and neck squamous cell carcinoma (HNSCC) is a predictor of recurrence and patients with minimal residual disease may benefit from adjuvant therapy with temsirolimus, an mTOR inhibi